Revised forecast
Fiscal year ending June 2026 · Full yearPrevious forecast published Announced on 31 October 2025The bar length represents the relative magnitude of change, based on the item that changed the most in this document.
Although revenue was broadly in line with the forecast, operating profit and subsequent profit items fell below forecast because one-time expenses were recognized, including impairment losses associated with the decline in Tabikobo’s share price, impairment losses resulting from the sale of overseas consolidated second-tier subsidiaries and other matters, and valuation losses on operating investment securities.
In the consolidated financial statements, ¥191 million in impairment losses on Tabikobo’s goodwill and ¥191 million in impairment losses associated with losses on the transfer and valuation of shares held by an overseas consolidated subsidiary, totaling ¥382 million, were recognized under other expenses. In the non-consolidated financial statements, a ¥1,000 million valuation loss on shares of affiliates was recognized.
| Item | Details |
|---|---|
| Net Sales | ¥26,000 million → ¥25,638 million（-1.4%） |
| Operating profit | ¥1,800 million → ¥1,100 million（-38.9%） |
| Profit attributable to owners of the parent | ¥1,000 million → ¥466 million（-53.4%） |
| Net income per share | 134.49 yen → 63.36 yen（-52.9%） |
| Fiscal Period Covered | Fiscal year ending June 2026 |
| Period Covered | Full year |
| Publication date of previous forecast | Announced on 31 October 2025 |
| Previous-period results | Fiscal year ended June 2025: revenue ¥25,370 million, operating loss ¥1,155 million, loss before tax ¥1,290 million, profit for the period ¥2,069 million, profit for the period attributable to owners of the parent ¥1,711 million, basic loss per share ¥230.24 |
| Reason for the revision | Although revenue was broadly in line with the forecast, operating profit and subsequent profit items fell below forecast because one-time expenses were recognized, including impairment losses associated with the decline in Tabikobo’s share price, impairment losses resulting from the sale of overseas consolidated second-tier subsidiaries and other matters, and valuation losses on operating investment securities. |
| Details and amount of extraordinary loss | In the consolidated financial statements, ¥191 million in impairment losses on Tabikobo’s goodwill and ¥191 million in impairment losses associated with losses on the transfer and valuation of shares held by an overseas consolidated subsidiary, totaling ¥382 million, were recognized under other expenses. In the non-consolidated financial statements, a ¥1,000 million valuation loss on shares of affiliates was recognized. |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (2)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Although revenue was broadly in line with the forecast, one-time expenses were recognized, including impairment losses associated with the decline in Tabikobo’s share price, impairment losses resulting from the sale of an overseas consolidated second-tier subsidiary and other matters, and valuation losses on operating investment securities in the Investment segment.